CXCL13: biomarker evidence

CXCL13 appears in 1 entry of the OSMF biomarker atlas, covering Multiple Sclerosis. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Multiple Sclerosis

Where CXCL13 is reported

ConditionDirectionCompared againstAssociated symptomsSource
Multiple Sclerosis↕ inconsistentpostmortem MS cases with low levels of meningeal inflammation and GM demyelinationhigh levels of meningeal inflammation and GM demyelinationMagliozzi et al. 2018

Frequently asked questions

In which conditions is CXCL13 altered?

In the OSMF atlas CXCL13 is reported in Multiple Sclerosis. It is mixed in 1 across 1 entries.

Is there a standard clinical test for CXCL13?

The atlas entries for CXCL13 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal CXCL13 result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). CXCL13 across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/cxcl13.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.